Newswise — The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment. Dr. Goldfine is co-head of an ongoing clinical trial comparing results of two types of bariatric surgery with a lifestyle intervention program, the SLIMM-T2D trial (http://bit.ly/cioCpy).
RSS